Clinical Trial

Playing Game to Learn About Children's Vaccine Project

Recruiting
View on ClinicalTrials.gov →
Summary
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-02; most recent amendment 2026-05-18.
Trial Details
NCT Number NCT05984849
Lead Sponsor Michigan State University
Conditions HPV, Vaccine-Preventable Diseases
Enrollment 180 participants
Start Date 2025-10-27
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-20